Developments in fluorescent probes for receptor research

Drug Discovery Today

Volumn 14, Issue 13-14, 2009, Pages 706-712

  Leopoldo, Marcello ^a   Lacivita, Enza ^a   Berardi, Francesco ^a   Perrone, Roberto ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; FLUORESCENT DYE; RECEPTOR;

AMINO TERMINAL SEQUENCE; ANTIBODY LABELING; BINDING AFFINITY; BIOMEDICINE; CARBOXY TERMINAL SEQUENCE; CELL LABELING; CORRELATION ANALYSIS; DRUG RESEARCH; DRUG SCREENING; DRUG STRUCTURE; ENDOCYTOSIS; FLUORESCENCE MICROSCOPY; FLUORESCENCE POLARIZATION; FLUORESCENCE SPECTROSCOPY; HIGH THROUGHPUT SCREENING; HUMAN; LIGAND BINDING; MOLECULAR BIOLOGY; MOLECULAR PROBE; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NONHUMAN; PHYSICAL CHEMISTRY; PROTEIN DETERMINATION; RECEPTOR BINDING; REVIEW;

ANIMALS; BIOMEDICAL RESEARCH; DRUG DISCOVERY; FLUORESCENCE POLARIZATION; FLUORESCENT DYES; HUMANS; RECEPTORS, CELL SURFACE; SPECTROMETRY, FLUORESCENCE;

EID: 67649321457     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2009.03.015     Document Type: Review

References (47)

1. Anderson M.J., and Cohen M.W. Fluorescent staining of acetylcholine receptors in vertebrate skeletal muscle. J. Physiol. 237 (1974) 385-400
2. Atlas D., and Levitzki A. Probing of beta-adrenergic receptors by novel fluorescent beta-adrenergic blockers. Proc. Natl. Acad. Sci. U.S.A. 74 (1977) 5290-5294
3. Wang S., et al. Evidence for hydrophobic interaction between galanin and the GalR1 galanin receptor and GalR1-mediated ligand internalization: fluorescent probing with a fluorescein-galanin. Biochemistry 37 (1998) 9528-9535
4. Zhong Z.H., et al. Insulin binding monitored by fluorescence correlation spectroscopy. Diabetologia 44 (2001) 1184-1188
5. Yates A.S., et al. Chemical modification of the naphthoyl 3-position of JWH-015:In search of a fluorescent probe to the cannabinoid CB2 receptor. Bioorg. Med. Chem. 15 (2005) 3758-3762
6. Balboni G., et al. Highly selective fluorescent analogue of the potent delta-opioid receptor antagonist Dmt-Tic. J. Med. Chem. 47 (2004) 6541-6546
7. Bai M., et al. MBC94, a conjugable ligand for cannabinoid CB2 receptor imaging. Bioconjug. Chem. 19 (2008) 988-992
8. Middleton R.J., et al. New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cells. J. Med. Chem. 50 (2007) 782-793
9. Berque-Bestel I., et al. Synthesis and characterization of the first fluorescent antagonists for human 5-HT4 receptors. J. Med. Chem. 46 (2003) 2606-2620
10. Kuder K., and Kieć-Kononowicz K. Fluorescent GPCR ligands as new tools in pharmacology. Curr. Med. Chem. 15 (2008) 2132-2143
11. Middleton R.J., and Kellam B. Fluorophore-tagged GPCR ligands. Curr. Opin. Chem. Biol. 9 (2005) 517-525
12. Höltke C., et al. A fluorescent photoprobe for the imaging of endothelin receptors. Bioconjug. Chem. 18 (2007) 685-694
13. Zhou M., et al. Peptide-labeled quantum dots for imaging GPCRs in whole cells and as single molecules. Bioconj. Chem. 18 (2007) 323-332
14. Correa F.M., et al. Fluorescent probes of alpha- and beta-adrenergic and opiate receptors: biochemical and histochemical evaluation. Neurosci. Lett. 16 (1980) 47-53
15. Kolb V.M., et al. Fluorescent probes for opioid receptors. Life Sci. 33 (1983) 423-426
16. Kolb V.M., et al. Synthesis and pharmacological characterization of fluorescent opioid receptor probes. Pharm. Res. 2 (1985) 266-271
17. Koman A., et al. Prolonged receptor blockade by opioid receptor probes. Pharm. Res. 3 (1986) 56-60
18. Korlipara V., et al. Fluorescent N-benzylnatrindole analogues as potential opioid receptor probes. Eur. J. Med. Chem. 32 (1997) 171-174
19. Kshirsagar T., et al. NTI4F: a non-peptide fluorescent probe selective for functional delta opioid receptors. Neurosci. Lett. 249 (1998) 83-86
20. Tahtaoui C., et al. Fluorescent pirenzepine derivatives as potential bitopic ligands of the human M1 muscarinic receptor. J. Med. Chem. 47 (2004) 4300-4315
21. ®-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes. Br. J. Pharm. 146 (2005) 1069-1081
22. Vázquez M.E., et al. 6-N,N-dimethylamino-2, 3-naphthalimide: a new environment-sensitive fluorescent probe in delta- and mu-selective opioid peptides. J. Med. Chem. 49 (2006) 3653-3658
23. Krieger F., et al. Fluorescent agonists for the Torpedo nicotinic acetylcholine receptor. Chembiochem 9 (2008) 1146-11146
24. Jaiswal J.K., and Simon S.M. Potentials and pitfalls of fluorescent quantum dots for biological imaging. Trends Cell Biol. 14 (2004) 497-504
25. Edwards B.W., et al. Agonist-antagonist dilemma in molecular imaging: evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor. Bioconjug. Chem. 19 (2008) 192-200
26. Oheim M., et al. Principles of two-photon excitation fluorescence microscopy and other nonlinear imaging approaches. Adv. Drug Deliv. Rev. 58 (2006) 767-769 by stimulated emission depletion microscopy. Neuroscience, 144, 135-143
27. Xu C., and Webb W.W. Measurement of two-photon excitation cross sections of molecular fluorophores with data from 690 to 1050 nm. J. Opt. Soc. Am. B 13 (1996) 481-491
28. Cai M., et al. Real time differentiation of G-protein coupled receptor (GPCR) agonist and antagonist by two photon fluorescence laser microscopy. J. Am. Chem. Soc. 126 (2004) 7160-7161
29. Zeng C., et al. Subcellular localization of sigma-2 receptors in breast cancer cells using two-photon and confocal microscopy. Cancer Res. 67 (2007) 6708-6716
30. Hell S.W. Toward fluorescence nanoscopy. Nat. Biotechnol. 21 (2003) 1347-1355
31. Hell S.W. Microscopy and its focal switch. Nat. Methods 6 (2009) 24-32
32. Kellner R.R., et al. Nanoscale organization of nicotinic acetylcholine receptors revealed by stimulated emission depletion microscopy. Neuroscience 144 (2007) 135-143
33. http://www.mpibpc.mpg.de/groups/hell/STED_Dyes.html
34. Boyarskiy V.P., et al. Photostable, amino reactive and water-soluble fluorescent labels based on sulfonated rhodamine with a rigidized xanthene fragment. Chemistry 14 (2008) 1784-1792
35. Briddon S.J., and Hill S.J. Pharmacology under the microscope: the use of fluorescence correlation spectroscopy to determine the properties of ligand-receptor complexes. Trends Pharmacol. Sci. 28 (2007) 637-645
36. Hegener O., et al. Dye-labeled benzodiazepines: development of small ligands for receptor binding studies using fluorescence correlation spectroscopy. J. Med. Chem. 47 (2004) 3600-3605
37. Briddon S.J., et al. Application of fluorescence correlation spectroscopy to the measurement of agonist binding to a G-protein coupled receptor at the single cell level. Faraday Discuss. 126 (2004) 197-207
38. 3 receptor in plasma membranes of live biological cells. Biochemistry 42 (2003) 877-884
39. 3 adenosine receptors exist within heterogeneous complexes in membrane microdomains of individual living cells. FASEB J. 22 (2008) 850-860
40. http://www.cellaura.com/page/what-cellAura-do/index.htm
41. Sportsman J.R., and Leytes L.J. Miniaturization of homogeneous assays using fluorescence polarization. Drug Discov. Today: HTS Suppl. 1 (2000) 27-32
42. Adamczyk M., et al. Synthesis of a novel fluorescent probe for estrogen receptor. Bioorg. Med. Chem. Lett. 6 (2002) 1283-1285
43. DeGrazia M.J., et al. Synthesis of a high-affinity fluorescent PPARγ ligand for high-throughput fluorescence polarization assays. Bioorg. Med. Chem. 11 (2003) 4325-4332
44. Ramakrishna S., et al. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARα/γ activator. Anal. Biochem. 363 (2007) 263-274
45. Peterson K.J., et al. A fluorescence polarization assay for identifying ligands that bind to vascularendothelial growth factor. Anal. Biochem. 378 (2008) 8-14
46. Singleton D.H., et al. Fluorescently labeled analogues of dofetilide as high-affinity fluorescence polarization ligands for the human ether-a-go-go-related gene (hERG) channel. J. Med. Chem. 50 (2007) 2931-2941
47. Albizu L., et al. Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands. J. Med. Chem. 50 (2007) 4976-4985